New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
JDOCvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with JDOC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
JDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/13/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | JDOC ETF 2 | -5.93%– | -4.12%– | -4.05%– | +6.14%– | n/a– | n/a– |
| Flows | JDOC ETF 2 | -– | -– | -– | -$85K– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | JDOC ETF 2 | +13.07%– | +16.33%– | n/a– | n/a– |
| Max drawdown | JDOC ETF 2 | -7.03%– | -11.54%– | n/a– | n/a– |
| Max drawdown duration | JDOC ETF 2 | 50d– | 192d– | n/a– | n/a– |
Trading data
JDOC | ETF 2 | |
Last sale 3/13/2026 at 1:30 PM | $55.49 | – |
| Previous close 03/12/2026 | $55.86 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
JDOC | ETF 2 | |
|---|---|---|
| Last price | $55.49 | – |
| 1D performance | -0.65% | – |
| AuM | $8.33 M | – |
| E/R | 0.65% | – |
Characteristics
JDOC | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | J.P. Morgan Asset Management | – |
| Benchmark | - | – |
| N° of holdings | 53 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
JDOC
USA
67.95%
Other
32.05%
ETF 2
Sectors
JDOC
Health Care
90.99%
Other
9.01%
ETF 2
Advertisement
Diversification
JDOC
Total weight of top 15 holdings out of 15
57.94%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
JDOC
JOHNSON&JOHNSON
7.29%
LILLY
7.16%
ABBVIE
5.40%
MERCK & CO INC
4.97%
ASTRAZENECA
4.83%
DK0062498333
3.86%
UNITEDHEALTH GRP
3.41%
DANAHER
3.38%
MEDTRONIC PLC
3.01%
ROCHE
2.91%
BRISTOL-MYERS SQUIBB
2.44%
ARGEN X NV
2.41%
BOSTON SCIENTIFIC
2.41%
CVS HEALTH CORP
2.30%
REGENERON PHARMACEUTICALS
2.16%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
